Anti-PD-1/PD-L1 therapy for renal cell carcinoma: challenges in the development of predictive biomarkers

Expert Rev Anticancer Ther. 2022 Jul;22(7):667-669. doi: 10.1080/14737140.2022.2087631. Epub 2022 Jun 14.
No abstract available

Keywords: PD-L1 expression; anti-PD-1/PD-L1 therapy; biomarker; peripheral blood biomarkers; renal cell carcinoma.

Publication types

  • Editorial

MeSH terms

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Carcinoma, Renal Cell* / drug therapy
  • Humans
  • Kidney Neoplasms* / drug therapy
  • Programmed Cell Death 1 Receptor

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Programmed Cell Death 1 Receptor